SEC Form 4 · accession 0001437749-16-029423
Nuvectra Corp · NVTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathy Jo Fahey
Officer — VP of Regulatory & Clinical
Period of report
Apr 8, 2016
Accepted (ET)
Apr 12, 2016 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001648893
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2016 | A | 3,741 | $0.00 | A | 3,741 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options - EmployeeF1 | $6.87 | Apr 8, 2016 | A | 3,741 | A | — | Apr 7, 2026 | Common Stock | 3,741 | 3,741 | D |
Explanation of responses
- F1The option vests 33.34% on the first annual anniversary of the grant date and 8.33% on each of the eight three month periods thereafter, resulting in vesting in full on the third annual anniversary of the grant date.